EC Number |
Inhibitors |
Structure |
---|
2.7.11.10 | N,8-dimethyl-2-phenyl-8H-imidazo[4,5-d][1,3]oxazolo[5,4-b]pyridin-5-amine |
- |
|
2.7.11.10 | N,8-dimethyl-2-phenyl-8H-imidazo[4,5-d][1,3]thiazolo[5,4-b]pyridin-5-amine |
- |
|
2.7.11.10 | N,N-dimethyl-3-[(4-[[(6-phenylisoquinolin-7-yl)oxy]methyl]piperidin-1-yl)sulfonyl]propan-1-amine |
- |
|
2.7.11.10 | N-(1,8-dimethylimidazo[1,2-a]quinoxalin-4-yl)ethane-1,2-diamine |
- |
|
2.7.11.10 | N-(2-aminoethyl)-4-([4-(1-benzothiophen-2-yl)pyrimidin-2-yl]amino)benzamide |
IC50 for the IKK complex is 0.0044 mM |
|
2.7.11.10 | N-(2-dimethyl-aminoethyl)-4-([4-(1-benzothiophen-2-yl)pyrimidin-2-yl]amino)benzamide |
IC50 for the IKK complex is 300 nM, cellular profile |
|
2.7.11.10 | N-(2-pyrrolidin-1-yl-ethyl)-4-([4-(1-benzothiophen-2-yl)pyrimidin-2-yl]amino)benzamide |
IC50 for the IKK complex is 500 nM |
|
2.7.11.10 | N-(3,5-bis-trifluoromethylphenyl)-5-chloro-2-hydroxybenzamide |
- |
|
2.7.11.10 | N-(3-methyl-butyl)-4-([4-(1-benzothiophen-2-yl)pyrimidin-2-yl]amino)benzamide |
IC50 for the IKKbeta is above 0.1 mM |
|
2.7.11.10 | N-(3-[2-imino-6-methyl-3-[(3-nitrophenyl)methyl]-4-oxo-1,2,3,4-tetrahydropyrimidin-5-yl]propyl)-4-methylbenzene-1-sulfonamide |
NCI0211135, complete inhibition at 0.1 mM |
|